Olema Pharmaceuticals Inc (OLMA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -162,451 | -116,390 | -74,173 | -30,389 | -129,474 |
| Depreciation Amortization | 490 | 303 | 260 | 128 | 393 |
| Accounts payable and accrued liabilities | 4,598 | -1,175 | -3,566 | -4,309 | 2,510 |
| Other Working Capital | 2,775 | -1,362 | -5,780 | -16,282 | 9,164 |
| Other Operating Activity | 7,872 | 10,235 | 9,397 | 6,873 | 13,056 |
| Operating Cash Flow | $-146,716 | $-108,389 | $-73,862 | $-43,979 | $-104,351 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | N/A | -159 |
| Purchase Of Investment | -500,722 | -247,370 | -175,718 | -142,855 | -394,959 |
| Sale Of Investment | 344,962 | 253,794 | 164,869 | 97,772 | 301,592 |
| Investing Cash Flow | $-155,760 | $6,424 | $-10,849 | $-45,083 | $-93,526 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 3,000 | 3,000 | 3,000 | N/A | N/A |
| Common Stock Issued | 214,811 | -5,255 | -5,296 | 222 | 268,818 |
| Other Financing Activity | -6,514 | 0 | 0 | 0 | 0 |
| Financing Cash Flow | $211,297 | $-2,255 | $-2,296 | $222 | $268,818 |
| Beginning Cash Position | 139,480 | 139,480 | 139,480 | 139,480 | 68,539 |
| End Cash Position | 48,301 | 35,260 | 52,473 | 50,640 | 139,480 |
| Net Cash Flow | $-91,179 | $-104,220 | $-87,007 | $-88,840 | $70,941 |
| Free Cash Flow | |||||
| Operating Cash Flow | -146,716 | -108,389 | -73,862 | -43,979 | -104,351 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -159 |
| Free Cash Flow | -146,716 | -108,389 | -73,862 | -43,979 | -104,510 |